We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ICDs Found of Most Benefit to Sickest Patients

By HospiMedica staff writers
Posted on 06 Sep 2001
A study of cardioverter defibrillators (ICDs) has found that the devices save lives most often in the sickest patients. More...
Conducted by researchers at the University of Rochester Medical Center (NY, USA), the study was published in the September 1, 2001, issue of the American Journal of Cardiology.

The research involved 196 patients with implanted ICDs at various medical centers who had previously suffered at least one heart attack. The patients were separated into high-risk and low-risk groups and then monitored for an average of two years. The results showed that the ICDs were of most benefit to the sickest patients. Previously, it was thought that most patients who die of heart disease suffer from a progressive failure of the organ, so that it simply tires and stops pumping. An ICD would not be a useful treatment in these cases. More often, however, patients die from an abrupt malfunction of the heart rhythm. In such patients, an ICD can deliver a powerful jolt within seconds to shock the heart back into a normal rhythm.

"The bottom line is that the sickest patients receive the most benefits from ICDs,” said Arthur J. Moss, lead author of the study and a professor of medicine at the University of Rochester. "The other side of the coin is that patients with chronic disease, who still have relatively good heart function, are not helped by defibrillators.”




Related Links:
Univ. of Rochester

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.